Redesca 60 mg (Enoxaparin Sodium SOLUTION) 60 MG

REDESCA 60 MG is an injectable solution containing enoxaparin sodium, used for blood thinning and clot prevention. Ideal for managing conditions requiring anticoagulation therapy.

Strength

60 MG

Manufacturer / TM Owner

SHENZHEN TECHDOW PHARMACEUTICAL CO., LTD.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REDESCA 60 MG is primarily used for preventing and treating blood clots. It is often administered to patients undergoing surgery or those with conditions that increase the risk of clot formation. Enoxaparin sodium, the active ingredient, helps to thin the blood, reducing the likelihood of clots. This medication is commonly prescribed for conditions like deep vein thrombosis and pulmonary embolism.

Side Effects

Common effects of REDESCA 60 MG may include bruising, bleeding, and pain at the injection site. Some users might experience swelling or redness where the injection was administered. These effects are generally mild and temporary, but any persistent or severe symptoms should be discussed with a healthcare provider.

Precautions & Warnings

REDESCA 60 MG should be handled with care to avoid contamination. It is important to follow proper injection techniques and dispose of used needles safely. Patients with a history of bleeding disorders or allergies to enoxaparin sodium should use this medication with caution. Always consult a healthcare provider before starting any new medication.

Avoid Interactions

REDESCA 60 MG may interact with other blood-thinning medications, increasing the risk of bleeding. It is also important to be cautious when using this medication with nonsteroidal anti-inflammatory drugs (NSAIDs) or other drugs that affect blood clotting. Alcohol consumption should be limited, as it can enhance the effects of enoxaparin sodium.

Frequently Asked Questions

REDESCA 60 MG is used to prevent and treat blood clots, often in patients undergoing surgery or with conditions that increase clot risk.

REDESCA 60 MG is administered intravenously. It is important to follow the instructions provided by a healthcare provider for proper administration.

Common side effects include bruising, bleeding, and pain at the injection site. Any persistent or severe symptoms should be discussed with a healthcare provider.

REDESCA 60 MG may interact with other blood-thinning medications and NSAIDs. Always consult a healthcare provider before combining medications.

Patients with a history of bleeding disorders or allergies to enoxaparin sodium should use REDESCA 60 MG with caution. Consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.